Rejected at 5:42 p.m. Feb, 21, 2024 ] by herstein.jacob
Author: shahar
Co-authors: NiceJewishBoy
Related Note: 1488765299956
Rationale for change

I have done this card many times - and it is very difficult to memorize

I was thinking how to make this card more orginize and simple to understand , so i suggest my change - please consider the change

I DIDNT change any of the Content!

Rejection reason

No significant improvement being made

Text Text
Extra
- PCC is preferred over FFP if both are available

- Only use PCC / FFP if patient on warfarin is actively bleeding (use vitamin K if patient has a supratherapeutic INR but is not bleeding)

- Vitamin K to resynthesize clotting factors in liver

- PCC results in rapid reversal of warfarin (factors II, VII, IX, and X)

- FFP can be considered if PCC is not available but is slower / requires more volume infusion
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo

OME

Additional Resources
One by one
Empty field
#AK_Step2_v12::#UWorld::COMLEX::100532 #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::03_Specific_toxicity_treatments #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step2_v12::#Resources_by_rotation::Neuro::uw::zanki #AK_Step2_v12::#UWorld::Step::3737 #AK_Step2_v12::#UWorld::Step::4601 #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Biochemistry::12_Vitamins::06_Vitamin_K_Clinical_Implications #AK_Step1_v12::#UWorld::COMLEX::23821 #AK_Step1_v12::#UWorld::COMLEX::24559 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#SketchySurgery::02_Trauma,_Burns,_Critical_Care::03_Abdominal_Trauma::01_Hemorrhage_and_Hypovolemic_Shock #AK_Step1_v12::#UWorld::Step::709 #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#Subjects::Hematology::01_Hemostasis::04_Hypercoagulable_State::Warfarin_Skin_Necrosis #AK_Step2_v12::#AMBOSS::xx0EAR #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::Original_decks::Zanki_Step_2::Neuro::UW_Neuro #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step1_v12::#AMBOSS::#Self_Assessment !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::Neurology::2-UWorld #AK_Step2_v12::#SketchySurgery::02_Trauma,_Burns,_Critical_Care::04_Head_and_Neck_Trauma::05_Moderate_and_Severe_Traumatic_Brain_Injury_2_Management #PANCE::GI::toxic_substance_ingestion #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#UWorld::Step::1448 #AK_Step2_v12::#UWorld::COMLEX::101384 #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step2_v12::#Resources_by_rotation::Peds::nbme::form_8 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::03_Heparin_vs_warfarin::*Warfarin #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step2_v12::#Resources_by_rotation::Neuro::uw::dorian !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step2_v12::#AMBOSS::wN0hWg #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step3_v12::#UWorld::5668 #AK_Step2_v12::#SketchyIM::00_Sketchy_Pearls::01_Clinical_Basics::02_Blood_Bank_Review #PANCE::EOR::Family_med #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step2_v12::Original_decks::Dorian::neuro::uw #AK_Step2_v12::Original_decks::Dorian::im::uw::neuro #AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::07_Anticoagulant_Drugs::Extra